These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38035160)

  • 1. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
    Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
    Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
    Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
    J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of "universal test and treat" program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia.
    Girum T; Yasin F; Wasie A; Shumbej T; Bekele F; Zeleke B
    AIDS Res Ther; 2020 May; 17(1):19. PubMed ID: 32423457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
    Mody A; Sikazwe I; Namwase AS; Wa Mwanza M; Savory T; Mwila A; Mulenga L; Herce ME; Mweebo K; Somwe P; Eshun-Wilson I; Sikombe K; Beres LK; Pry J; Holmes CB; Bolton-Moore C; Geng EH
    Lancet HIV; 2021 Dec; 8(12):e755-e765. PubMed ID: 34656208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis.
    Mugenyi L; Nanfuka M; Byawaka J; Agaba C; Mijumbi A; Kagimu D; Mugisha K; Shabbar J; Etukoit M
    PLoS One; 2022; 17(5):e0268226. PubMed ID: 35580126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda.
    Mugenyi L; Hansen CH; Mayaud P; Seeley J; Newton R; Nanfuka M; Abaasa A; Mugisha K; Etukoit M; Kaleebu P; Ruzagira E
    Front Public Health; 2023; 11():1187274. PubMed ID: 37361157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lost to follow up rate in the first year of ART in adults initiated in a universal test and treat programme: a retrospective cohort study in Ekurhuleni District, South Africa.
    Chauke P; Huma M; Madiba S
    Pan Afr Med J; 2020; 37():198. PubMed ID: 33505567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
    Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
    BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
    Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
    J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
    Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
    Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of reduced treatment adherence among HIV infected paediatric and adolescent populations in Nairobi at the onset of the UNAIDS Universal Test and Treat Program.
    Kabogo J; Muniu E; Wamunyokoli F; Musoke R; Songok E
    BMC Res Notes; 2018 Feb; 11(1):134. PubMed ID: 29452597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa.
    Larsen A; Cheyip M; Tesfay A; Vranken P; Fomundam H; Wutoh A; Aynalem G
    AIDS Behav; 2019 Feb; 23(2):375-385. PubMed ID: 30008050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of implementing universal test and treat in three correctional facilities in South Africa and Zambia.
    Mukora R; Smith HJ; Herce ME; Chimoyi L; Hausler H; Fielding KL; Charalambous S; Hoffmann CJ
    PLoS One; 2022; 17(8):e0272595. PubMed ID: 36006967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal analysis of client appointment adherence under Universal Test and Treat strategy: A stepped-wedge trial.
    Boeke CE; Khan S; Walsh FJ; Lejeune C; Hettema A; Spiegelman D; Okello V; Bärnighausen T
    HIV Med; 2021 Oct; 22(9):854-859. PubMed ID: 34293243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya.
    Kimanga DO; Oramisi VA; Hassan AS; Mugambi MK; Miruka FO; Muthoka KJ; Odhiambo JO; Yegon PK; Omoro GO; Mbaire C; Masamaro KM; Njogo SM; Barker JL; Ngugi CN
    PLoS One; 2022; 17(11):e0277675. PubMed ID: 36413522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal test and treat in relation to HIV disease progression: results from a stepped-wedge trial in Eswatini.
    Boeke CE; Khan S; Walsh F; Hettema A; Lejeune C; Spiegelman D; Okello V; Harwell J; Mazibuko S; Bärnighausen T
    HIV Med; 2021 Jan; 22(1):54-59. PubMed ID: 32876360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal test and treat in Cameroon: a comparative retrospective analysis of mortality and loss to follow-up before and after a strategic change in approach to HIV care.
    Bekolo CE; Ndeso SA; Moifo LL; Mangala N; Yimdjo TD; Ateudjieu J; Kouanfack C; Djam A; Tabah EN; Whegang S; Mapa-Tassou C; Tendongfor N; Nsagha DS; Choukem SP
    Pan Afr Med J; 2023; 45():191. PubMed ID: 38020352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
    Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
    J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test site predicts HIV care linkage and antiretroviral therapy initiation: a prospective 3.5 year cohort study of HIV-positive testers in northern Tanzania.
    Reddy EA; Agala CB; Maro VP; Ostermann J; Pence BW; Itemba DK; Safley D; Yao J; Thielman NM; Whetten K
    BMC Infect Dis; 2016 Sep; 16():497. PubMed ID: 27646635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.